Butane

Butane

SCHEMBL1173128

CC(=O)OC(=O)C(N)CC(=O)O.CCCC

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ GRIK1 P39086 4/20 0.35
▸ GRIA4 P48058 1/20 0.35
▸ GRIK3 Q13003 1/20 0.35
▸ GRIK5 Q16478 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ S1PR1 P21453 1/20 0.35
▸ S1PR3 Q99500 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.33
▸ LMNA P02545 2/20 0.33
▸ FFAR3 O14843 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ GRIK2 Q13002 2/20 0.33
▸ GPR84 Q9NQS5 4/20 0.32
▸ SLC1A3 P43003 1/20 0.32
▸ SLC1A2 P43004 1/20 0.32
▸ SLC1A1 P43005 1/20 0.32
▸ BHMT Q93088 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1824385 0.94 ALOX15 (0.38) GRIK1GRIA4GRIK3GRIK5ALOX15
Phosphine SCHEMBL27661468 0.92 ALOX15 (0.37) GRIK1GRIA4GRIK3GRIK5ALOX15
SCHEMBL27856278 0.92 ALOX15 (0.37) GRIK1GRIA4GRIK3GRIK5ALOX15
SCHEMBL4656227 0.92 ALOX15 (0.37) GRIK1GRIA4GRIK3GRIK5ALOX15
Methane SCHEMBL28312792 0.92 ALOX15 (0.37) GRIK1GRIA4GRIK3GRIK5ALOX15
Acetic Acid Pentyl Ester SCHEMBL28489335 0.84 ALDH1A1 (0.49) S1PR1S1PR3ALDH1A1TSHRGPR84
Phosphine SCHEMBL28022453 0.82 CA2 (0.35) GRIK1ALOX15LMNASMN1; SMN2
D-Glutamate SCHEMBL28289202 0.81 GRM8 (0.58) GRIK1GRIA4GRIK3GRIK5ALOX15
SCHEMBL1653844 0.81 SLC22A6 (0.39) GRIK1GRIA4GRIK3GRIK5LMNA
SCHEMBL29069490 0.79 ALDH1A1 (0.50) GRIK1GRIA4GRIK3GRIK5S1PR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4626396-B1 A PERSONAL CARE COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2026-05-20 — — EP disclosed
US-20260027036-A1 A PERSONAL CARE COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2026-01-29 — — US disclosed
EP-4626396-A1 A PERSONAL CARE COMPOSITION Unilever IP Holdings B.V. (NL) 2025-10-08 — — EP disclosed
US-20250302732-A1 BIOBASED, BIODEGRADABLE COMPOSITE POWDER FOR USE IN COSMETICS GRANT INDUSTRIES, INC. (US) 2025-10-02 — — US disclosed
US-12337059-B2 Biobased, biodegradable composite powder for use in cosmetics GRANT INDUSTRIES, INC. (US) 2025-06-24 — — US disclosed
WO-2024115001-A1 A PERSONAL CARE COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2024-06-06 — — WO disclosed
US-20230265268-A1 THERMOPLASTIC ELASTOMER COMPOSITION POLYMAX THERMOPLASTIC ELASTOMERS, LLC 2023-08-24 — — US disclosed
EP-4213802-A1 BIOBASED, BIODEGRADABLE COMPOSITE POWDER FOR USE IN COSMETICS Grant Industries, Inc. (US) 2023-07-26 — — EP disclosed
US-20220087928-A1 BIOBASED, BIODEGRADABLE COMPOSITE POWDER FOR USE IN COSMETICS GRANT INDUSTRIES, INC. (US) 2022-03-24 — — US disclosed
WO-2022061213-A1 BIOBASED, BIODEGRADABLE COMPOSITE POWDER FOR USE IN COSMETICS GRANT INDUSTRIES, INC. (US) 2022-03-24 — — WO disclosed
WO-2006098980-A2 OIL GELS OF CONTROLLED DISTRIBUTION BLOCK COPOLYMERS AND ESTER OILS KRATON POLYMERS RESEARCH B.V. (NL) 2006-09-21 — — WO disclosed
US-20060205904-A1 Oil gels of controlled distribution block copolymers and ester oils UBS AG, STAMFORD BRANCH, AS COLLATERAL AGENT 2006-09-14 — — US disclosed
US-20060205849-A1 Oil gels of controlled distribution block copolymers and ester oils KRATON POLYMERS U.S. LLC 2006-09-14 — — US disclosed
EP-1685230-A1 CLEANING COMPOSITIONS Reckitt Benckiser Inc. (US) 2006-08-02 — — EP disclosed
EP-1141111-B1 GEL COMPOSITIONS PENRECO (US) 2005-08-03 — — EP disclosed
WO-2005052110-A1 CLEANING COMPOSITIONS RECKITT BENCKISER INC (US) 2005-06-09 — — WO disclosed
US-6881776-B2 Gel compositions PENRECO (US) 2005-04-19 — — US disclosed
US-20050004274-A1 Gel compositions HEALY LIN LU (US) 2005-01-06 — — US disclosed
EP-1256336-A2 Two-phase gel composition Penreco (US) 2002-11-13 — — EP disclosed
US-20020055562-A1 Gel compositions WILMINGTON TRUST, NATIONAL ASSOCIATION 2002-05-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260027036-A1 A PERSONAL CARE COMPOSITION IL5, C9, IL33 GRIK1 2955/4885GRIA4 4306/4885GRIK3 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback